McDonnell Boehnen Hulbert & Berghoff LLP to Exhibit at 2015 BIO International Convention in Philadelphia

McDonnell Boehnen Hulbert & Berghoff LLP will be participating as an exhibitor at the 2015 BIO International Convention (“BIO”) set for June 15-18 in Philadelphia. We invite you to visit us at Booth #3226 in the exhibit hall to meet our attorneys, learn more about our services and enter or raffle. Billed as the largest global event for the biotechnology industry, 2015 BIO is organized by the Biotechnology Industry Organization. The organization represents more than 1,100 biotechnology companies, academic institutions. state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products.

2015 BIO covers the wide spectrum of life science innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy are just a few of the industries represented. Thousands of leaders from over 65 countries are expected to attend 2015 BIO. The key elements of the event are education, networking, BIO Business Forum partnering and the 1,700 companies showcasing the latest technologies, products and services in the BIO Exhibition. View complete details at http://convention.bio.org/2015/.  

MBHB Partners in BIO Media Coverage

• MBHB Partner Andrew Williams Authors Article Entitled, “Biosimilars at the Federal Circuit – Can the Parties Be Compelled to Dance?” (as published in the online edition of BIOTechNOW)
• MBHB Partners Kevin Noonan and Donald Zuhn Quoted in LSIPR Article Entitled, “BIO 2015: Picking apart the Federal Circuit’s Sequenom ruling” (as published in the online edition of Life Sciences Intellectual Property Review)
• MBHB Partner Kevin Noonan Authors Article Entitled, “FDA Acts on Biosimilars” (as published in the online edition of BIOTechNOW)